ArticleJournal of hepatocellular carcinoma2026
The Fibrinogen-to-Albumin Ratio (FAR) Predicts Prognosis in Hepatocellular Carcinoma Patients After Liver Transplantation: Development and Validation of a Novel Nomogram.
Article in Journal of hepatocellular carcinoma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond Single Biomarkers: A Multidimensional Risk Score for Improved Post-Transplant Prognosis Prediction in Hepatocellular Carcinoma.Journal of inflammation research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Hepatocellular carcinoma (HCC) is a common liver tumor. The fibrinogen-albumin ratio (FAR) combined inflammation and nutrition, may have value in the prognosis assessment of HCC patients undergoing liver transplantation. Materials and Methods: A total of 239 patients were enrolled in the study and randomly divided into a training set and a validation set in a 7:3 ratio. The optimal cut-off value of FAR was determined by Maximally Selected Rank Statistics, and univariate and multivariate Cox regression analyses were conducted to evaluate the predictive value of FAR for overall survival (OS) and disease-free survival (DFS) in HCC patients after liver transplantation. Results: FAR had a non-linear relationship with OS and DFS, with the optimal cut-off value being 0.0623. Patients in the high FAR group had significantly poorer prognosis (P < 0.05). Multivariate Cox regression analysis further demonstrated that microvascular invasion and FAR ≥ 0.0623 were independent risk factors for OS and DFS. The prognostic prediction model based on FAR and microvascular invasion had good predictive performance and clinical utility. Conclusion: This preoperative FAR is an independent prognostic factor for OS and DFS in HCC patients undergoing liver transplantation. The Nomogram model based on FAR has good predictive performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.